- This event has passed.
NGS 2014 Dundee
May 7, 2014 - May 8, 2014
NGS 2014 DundeeConference: 7th - 8th May
The NGS Dundee has moved to Glasgow Please visit the NGS 2015 Glasgow pages for more details
The NGS 2014 Dundee took place on 7th & 8th May 2014. Check out these pages to see what our 2014 event was like!
It was a great pleasure for us to hold our Next Generation Sequencing conference: “NGS 2014 Dundee: Exomes, Genomes and Transcriptomes in Clinical Diagnostics”. This diagnostic conference and workshops took place this year at the Hannah Maclure Centre which is part of the Abertay University in Dundee, UK on the 7th & 8th May 2014 with a scientific committee consisting of experts in the area (Dr Paul Denny, Dr Darren Grafham, Dr Simon Patton, Dr Magnus Rattray). This conference looked at advances in Next Generation Sequencing (NGS) applications important to human disease. Invited speakers came from academic research and from clinical genetics labs that provide diagnostic services to patients. The NGS application areas covered included:
- RNA Seq (Transcriptome)
- Exomes and Genomes
- Methylation based Epigenetics
- Microbiome in relation to human disease
The agenda included talks so that registrants got a higher level overview of the advances in these applications as well as workshops that gave more technical information to allow registrants to gain a working knowledge of these applications. To view the speakers and agenda please click here.
Why should you attend next year NGS Event?
Excellent Networking Possibilities Registrants to our NGS events have overwhelmingly stated that a conference size of under 100-120 people allows them to get the best out of networking and meeting people so that the discussions are of high quality and result in real collaborations. We will be keeping a strict size limit on the Dundee event to ensure a continued benefit to our registrants.
Great scientific agenda of talks and workshops selected by academic scientific committee Our bioteXcel NGS events for 2014 have a scientific committee consisting of renowned academic experts
Poster Presentations and possibility for publication in Open-Access journal We will welcome poster submissions free of charge and these will reviewed by our scientific academic committee and selected posters will be published in BioDiscovery – the first Scottish Open-Access journal in the field of life sciences and medicine and edited by Professor Sir David Lane. View here.
Drinks Reception hosted by the Lord Provost of Dundee Whilst registrants will be offered coffee and snacks as well as excellent finger buffet hot lunches, they will also be invited on the first evening to a complimentary civic drinks reception hosted by the Lord Provost of Dundee in the city chambers. Following the civic reception there will be a networking dinner that can be booked at an extra cost.
Dundee – a city of discoveries and possibilities Dundee City Council have kindly sponsored this conference and subsidised tourism possibilities for all registrants to this event. This will include free and discounted access to local attractions (golf, shows, museums, castles and adventure activities) as well as discounts to cafés, bars and restaurants
Getting to Dundee is easy via 3 international airports (Edinburgh, Glasgow and Aberdeen) and a local airport connected to Stansted via Flybe. There are also direct bus and train connections from all major cities.
Who should attend this NGS Event?
- All NGS users, researchers and students
- NHS & Private Labs, Biotech Companies, CRO’s, Service Providers
- Computational Biology
- Data Analysis
- Data interpretation
- DNA Sequencing
- Infectious and inherited Diseases
- Molecular and Cell Biology
- Molecular Diagnostics
- Next Generation Sequencing
Agenda – NGS 2014 Dundee
|08.30 – 10.00:||Registration, Coffee|
|10.00 – 10.05:||Welcome – Professor Nikolai Zhelev, Chair Organising Committee of NGS 2014 Dundee|
|10.05 – 10.15:||Opening of NGS 2014 Dundee by Mr Mark Batho, Vice-Principal of Abertay University|
|10.15 – 10.45:||Collaborative Networking for NGS based partnerships by Dr Paul Denny, bioteXcel|
|10.45 – 11.30:||Dr Paul Westwood, Deputy Head, West of Scotland Genetic Services (KEYNOTE TALK) Insights into the Scottish Consortium Strategy on implementing NGS in Clinical Genetics|
|11.30 – 12.15:||TECHNOLOGY WORKSHOP – Redefining Reference Standards for Next Generation Sequencing Workflows by Dr Louisa Ludbrook, Horizon Diagnostics and International external quality assessment of diagnostic Next Generation Sequencing by Dr Kim Brugger|
|12.15 – 13.15:||Lunch, Exhibition and Networking|
|13.15 – 14.00:||TECHNOLOGY WORKSHOP –Next-generation variant effect predictions and data integration Dr Bas Vroling, Bio-Prodict, Nijmegen, The Netherlands|
|14.00 – 15.00:||Technology Panel Discussion – Dr Austin Diamond, Dr Paul Denny, Dr Paul Westwood, Dr Kim Brugger and led by Darren Grafham Panel Discussion on NGS Data storage vs. DNA sample storage & Re-sequencing|
|15.00 – 15.35:||Coffee, Exhibition and Networking|
|15.35 – 16.35:||TECHNOLOGY WORKSHOP – Long term NGS DATA Archiving by Jim Cook, Arkivum|
|16.35 – 17.05:||Dr Kevin Blighe, Sheffield Diagnostic Genetics Services Practical issues on filtering clinically-significant variants from whole exome data|
|17.30 – 18.45:||Civic Reception at City Chambers hosted by the Lord Provost of Dundee|
|19.00:||Networking Dinner (by prior booking only)|
|09.00 – 09.35:||Professor Neil Hall, Co-Director, Centre for Genomic Research, Liverpool The application of NGS in clinical microbiology, and the potential of The Pacific Biosciences single molecule sequencing platform|
|09.35 – 10.10:||Dr Sarah Ennis, Genomic Informatics Group Lead, University of Southampton QC aspects of NGS – and using NGS for studying Immune Disorders|
|10.10 – 10.45:||Coffee, Exhibition and Networking|
|10.45 – 11.20:||Dr Matthias Zilbauer, Lecturer and Honorary Consultant in Paediatric Gastroenterology, University of Cambridge Epigenetics in Inflammatory Bowel Disease|
|11.20 – 11.55:||Dr Santiago Uribe-Lewis, Cancer Research UK, Cambridge Research Institute Genome-wide data on cytosine hydroxymethylaiton in colon cancer|
|11.55 – 12.30:||Dr Mick Watson, Director of ARK-Genomics, The Roslin Institute, University of Edinburgh Exomes, transcriptomes, genomes, eipgenomes and metagenomes: applications of NGS to all areas of biological research|
|12.30 – 13.40:||Lunch, Exhibition and Networking|
|13.40 – 14.15:||Dr Melanie Febrer, NGS Service Facility, University of Dundee Genomic Sequencing Unit: a Dundee-based next generation sequencing facility|
|14.15 – 14.50:||Professor Geoff Barton, Head of Computational Biology, University of Dundee 48 RNA-seq replicates:lessons to be learned about experimental design and statistical analysis in differential gene expression|
|14.50 – 15.25:||Coffee, Exhibition and Networking|
|15.25 – 16.00:||Dr Martin Taylor, Program Leader, Human Genetics Unit MRC IGMM, University of Edinburgh Quantifying SNV detection sensitivity in exome and genome sequencing|
|16.00 – 16.35:||Dr Chris Cole, Department of Bioinformatics and Computing, University of Dundee Not all exomes are equal: a comparison of 3 commercially available exome capture kits|
|16.35 – 16.45:||Closing Comments|
Arkivum provides a large scale, long term, cost effective data archiving service with a unique 100% data integrity guarantee.
With large volumes of data – which are growing year on year – which need to be retained, organisations face ever increasing storage costs as they retain this archive data on expensive media such as disk.
Arkivum’s full managed service provides an elegant, low cost, highly secure and easy to use solution to these challenges.
The reductions in capital expenditure, improvements in operational efficiency and the certainty of compliance means that our clients see significant benefits in a very short timescale.
Cambridge Bioscience is a leading distributor of life science products with a passion for bringing new and exciting technologies to researchers. Working with over 50 specialist suppliers around the world, we offer an innovative, extensive and diverse range of high quality products, services and instruments supporting research in the areas of next-generation sequencing, exosomes, molecular biology, epigenetics, cell culture, cell analysis and much more.
Cambridge Bioscience – A Great Choice For Life Science Research.
Takara Bio Europe and Clontech Laboratories are members of the Takara Bio Group, a leading supplier of tools for life scientists worldwide.
Through our brand names TAKARA® and CLONTECH® we develop innovative technologies in the fields of Cell Biology, Molecular Biology and Proteomics.
Takara Bio holds worldwide patents on Long and Accurate (LA) PCR, and has a reputation for producing high-performance PCR reagents and kits, including Ex Taq™, LA Taq™, PrimeSTAR™ Max DNA Polymerases. Takara Bio has developed an extensive portfolio of Real-time PCR and RT-PCR kits.
Clontech Laboratories, Inc. develops, manufactures and distributes a wide range of life science research reagents under the Clontech brand. Key products include SMARTer™ cDNA synthesis kits for next generation sequencing, high-performance qPCR and PCR reagents, RT enzymes, the innovative In-Fusion™ cloning system, Tet-based inducible gene expression systems, Lenti X™ gene delivery systems and Living Colors® Fluorescent Proteins.
Source BioScience is an international diagnostic and genetic analysis services business serving the healthcare and life science research markets. The group has its headquarters in Nottingham, UK where it operates state of the art reference laboratory facilities, with additional UK laboratory facilities in Cambridge, Oxford and Motherwell, and European facilities in Berlin and Dublin. Source BioScience is CPA, GLP and GCP accredited and is licensed by the Human Tissue Authority.
Source BioScience Healthcare is a CPA, GLP and GCP accredited provider of healthcare diagnostics including cellular pathology, molecular diagnostics and cytology services to the NHS and other healthcare providers. With state-of-the-art reference laboratory facilities and draws from the expertise of over 60 of the leading RCPath qualified Pathologists. We can offer competitive pricing and provide rapid turnaround on all samples tested. Results are delivered securely via an easy access online portal. A number of the molecular diagnostic tests are companion tests for approved cancer drugs. These tests are available to PharmaBiotech clients in support of clinical trials and clinical research projects.
Source BioScience LifeSciences, the European leader in DNA sequencing and genomic services, has launched a new range of life science research products branded reSource™. reSource™ represents a range of high performance and cost effective products expanding the portfolio currently available through Source BioScience’s worldwide commercial network. The first products to be introduced under this brand are nucleic acid purification kits including high quality plasmid mini preps, PCR purification and gel extraction kits suitable for a broad range of applications.
Bio-Prodictis focused on delivering solutions for guiding scientific research in the field of protein engineering, molecular design and DNA diagnostics. We apply novel approaches to data mining, storage and analysis of protein data and combine these with state-of-the art analysis methods and visualization tools to create custom-built 3DM information systems for protein superfamilies.
3DM information systems are designed to facilitate the exploration of sequence-structure-function relations, and have successfully been used many times to elucidate the function of individual amino acids and predict the effects of mutations.
Horizon Diagnostics (HDx), a business unit of Horizon Discovery Ltd, is a leading provider of genetically defined, human genomic reference standards, including FFPE cell line sections and purified gDNA. These standards offer a sustainable source of reference material to laboratories, proficiency schemes and manufacturers, providing an unprecedented level of control.
Genotypic tumor profiling is becoming increasingly routine in the battle against cancer, and next generation sequencing (NGS) is offering a way to quickly and affordably establish baseline tumor genetics. Platforms such as MiSeq™ and Ion Torrent™ are increasingly used to interrogate tumors using pre-defined cancer panels such as Ampliseq™ or Truseq™. The range of steps involved in a NGS workflow, combined with the sheer number of biomarkers being screened, has the potential to create unprecedented levels of variability. In order to generate results with confidence, it is therefore important to manage potential workflow variability from sample extraction and sample selection through to sequencing and variant calling.
In response to the growing number of scientists using NGS instruments to study tumor genetics, Horizon Diagnostics has developed a range of Quantitative Multiplex Reference Standards for general use. These highly defined reference standard contain engineered endogenous mutations, each calibrated by digital PCR to a chosen allelic frequency ranging between 0.5% and 25%.